CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −2,792 | $50.58 | $141K | 92,313 |
| 2025-07-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −1,458 | $50.82 | $74K | 236,202 |
| 2025-07-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −46,076 | $50.24 | $2.3M | 190,126 |
| 2025-07-14 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,572 | $47.82 | $123K | 158,165 |
| 2025-07-14 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +7,587 | $5.01 | $38K | 65,665 |
| 2025-07-14 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,581 | $47.70 | $552K | 54,084 |
| 2025-07-14 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −7,587 | 372,946 | ||
| 2025-07-07 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +6,437 | $5.01 | $32K | 69,659 |
| 2025-07-07 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,581 | $46.67 | $540K | 58,078 |
| 2025-07-07 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −6,437 | 380,533 | ||
| 2025-06-30 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,572 | $50.50 | $130K | 160,737 |
| 2025-06-23 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −23,107 | $47.25 | $1.1M | 63,222 |
| 2025-06-17 | Chi Michael Chief Commercial Officer | Sale 10b5-1 | −17,102 | $59.75 | $1.0M | 278,654 |
| 2025-06-17 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −15,945 | $58.50 | $933K | 144,270 |
| 2025-06-17 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −49,165 | $59.45 | $2.9M | 95,105 |
| 2025-06-17 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,572 | $59.75 | $154K | 163,309 |
| 2025-06-17 | Becklund Irene PAO | Sale 10b5-1 | −8,485 | $59.75 | $507K | 712 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −2,792 | $56.35 | $157K | 160,215 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −40,120 | $56.44 | $2.3M | 245,074 |
| 2025-06-16 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −7,414 | $56.90 | $422K | 237,660 |
Page 29 of 37 · 739 trades